Even so, Glenn Micalizio, a chemist at Scripps, and his colleagues didn't develop into thinking about the compound as a consequence of its pharmaceutical opportunity. Instead, they recognized that its sophisticated carbon skeleton was a perfect target for testing a variety of reaction that t